Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
UTX in muscle regeneration — the right dose and the right time
Ling Liu, Thomas A. Rando
Ling Liu, Thomas A. Rando
Published March 21, 2016
Citation Information: J Clin Invest. 2016;126(4):1233-1235. https://doi.org/10.1172/JCI86798.
View: Text | PDF
Commentary

UTX in muscle regeneration — the right dose and the right time

  • Text
  • PDF
Abstract

Precise epigenetic modifications in stem cells control developmental programs and cell fate decisions. In particular, the addition or removal of trimethylation of histone 3 lysine 27 (H3K27me3) at lineage-specific genes has been linked to the repression of gene expression, and a precise balance of methyltransferases and demethylases within cells determines H3K27me3 levels. The demethylase UTX is essential for development and tissue homeostasis; however, a role for UTX in stem cell–mediated tissue regeneration is unknown. In this issue of the JCI, Dilworth and colleagues reveal that UTX and its demethylase activity are required in the muscle stem cell lineage for muscle regeneration in response to injury. Specifically, UTX mediates the removal of H3K27me3 in the promoter of the transcription factor myogenin, which regulates myogenic differentiation. The results of this study provide important insight into the contribution of epigenetic regulation in stem cell–mediated regeneration of adult tissues.

Authors

Ling Liu, Thomas A. Rando

×

Figure 1

Activation and differentiation of satellite cells require precise temporal expression of linage-specific transcription factors.

Options: View larger image (or click on image) Download as PowerPoint
Activation and differentiation of satellite cells require precise tempor...
Quiescent satellite cells (QSCs), marked by high levels of the transcription factor PAX7, begin to proliferate in response to muscle damage as the result of injury or disease. The myogenic regulatory factor MyoD drives differentiation of activated satellite cells (ASCs) toward the myogenic lineage. In these committed myocytes, myogenin upregulation promotes differentiation and formation of new muscle fibers. In this issue, Faralli et al. reveal that the demethylase UTX is required for the differentiation of satellite cell progeny and mediates removal of the repressive H3K27me3 mark at the myogenin promoter (6).
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts